Miraculins In Brief This Week: Miraculins, Alere; LabCorp; Plasticell, Pfizer, Cellzome Miraculins Passes ISO Certification Audit NEW YORK (GenomeWeb News) – Miraculins today said that it has successfully completed a two-part ISO certification audit conducted by the BSI Group. Miraculins Secures $986K Loan NEW YORK (GenomeWeb News) – Miraculins yesterday said that it has received a C$1 million (US$986,000) non-convertible secured loan from Gretchen Ross. Miraculins Launches Warrant Exercise Incentive Program The company said that if all warrants are exercised on or before expiration of the early exercise period, Miraculins expects to receive gross proceeds of around C$780,000. Miraculins Signs on Investment Firm Bloom Burton for Financial Advice Bloom Burton will provide financial modeling, an assessment of financing options, an evaluation of partnership opportunities, and other services. Apr 2, 2010 Miraculins Raises $505K in Private Placement Feb 10, 2010 Miraculins Offers up to $470K in Placement Jan 7, 2010 Miraculins Taps Inverness to Commercialize Preeclampsia Biomarkers Jun 25, 2009 Miraculins, DTL Partner on Pregnancy Disorder Dx Breaking News People in the News at Pacific Biosciences, Metabolon, NeoGenomics, More New Products Posted to GenomeWeb: Tethis, Invitae, PerkinElmer, More In Brief This Week: Thermo Fisher Scientific, Bruker, Quantum-Si, BioMérieux, More Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19 Palmetto Finalizes Positive LCD for Prostate Cancer Risk Tests Gene Expression, Histology Reveal Clues for Targeted Rheumatoid Arthritis Treatment The Scan Call for a Different Tack Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News. Wastewater Warning The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge. Can't Get in the Program Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports. Science Paper on Spatial-Controlled Genome Editing In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.